Thursday, October 6, 2016

Enfuvirtide




In the US, Enfuvirtide (enfuvirtide systemic) is a member of the drug class miscellaneous antivirals and is used to treat HIV Infection.

US matches:

  • Enfuvirtide

  • Enfuvirtide Subcutaneous

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

J05AX07

CAS registry number (Chemical Abstracts Service)

0159519-65-0

Chemical Formula

C204-H301-N51-O64

Molecular Weight

4492

Therapeutic Category

Antiviral agent, treatment of HIV infection

Chemical Name

Acetyl-L-tyrosyl-L-threonyl-L-seryl-L-leucyl-L-isoleucyl-L-histidyl-L-seryl-L-leucyl-L-isoleucyl-L-α-glutamyl-L-α-glutamyl-L-seryl-L-glutaminyl-L-asparaginyl-L-glutaminyl-L-glutaminyl-L-α-glutamyl-L-lysyl-L-asparaginyl-L-α-glutamyl-L-glutaminyl-L-α-glutam (WHO)

Foreign Names

  • Enfuvirtidum (Latin)
  • Enfuvirtid (German)
  • Enfuvirtide (French)
  • Enfuvirtida (Spanish)

Generic Names

  • Enfuvirtide (OS: USAN, BAN)
  • DP 178 (IS)
  • Pentafuside (IS)
  • R 698 (IS)
  • T 20 (IS: Trimeris)

Brand Names

  • Fuzeon
    Roche, Argentina; Roche, Austria; Roche, Australia; Roche, Bosnia & Herzegowina; Roche, Belgium; Roche, Bulgaria; Roche, Canada; Roche, Switzerland; Roche, Chile; Roche, Colombia; Roche, Czech Republic; Roche, Germany; Roche, Denmark; Roche, Ecuador; Roche, Spain; Roche, Finland; Roche, France; Roche, United Kingdom; Roche, Greece; Roche, Hungary; Roche, Ireland; Roche, Israel; Roche, Iceland; Roche, Italy; Roche, Luxembourg; Roche, Mexico; Roche, Netherlands; Roche, Norway; Roche, New Zealand; Roche, Poland; Roche, Portugal; Roche, Romania; Roche, Serbia; Roche, Sweden; Roche, Slovenia; Roche, Slovakia; Roche, Thailand; Roche, Taiwan; Roche, United States; Roche, Venezuela

International Drug Name Search

Glossary

BANBritish Approved Name
ISInofficial Synonym
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

No comments:

Post a Comment